These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 39088326)

  • 1. Protocol for analyzing TRAIL- and Fas-induced signaling complexes by immunoprecipitation from human cells.
    Davidovich P; Martin SJ
    STAR Protoc; 2024 Sep; 5(3):103126. PubMed ID: 39088326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cFLIP
    Davidovich P; Higgins CA; Najda Z; Longley DB; Martin SJ
    Cell Rep; 2023 Dec; 42(12):113476. PubMed ID: 37988267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspase-8 Acts in a Non-enzymatic Role as a Scaffold for Assembly of a Pro-inflammatory "FADDosome" Complex upon TRAIL Stimulation.
    Henry CM; Martin SJ
    Mol Cell; 2017 Feb; 65(4):715-729.e5. PubMed ID: 28212752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAIL.
    Grunert M; Gottschalk K; Kapahnke J; Gündisch S; Kieser A; Jeremias I
    Cell Death Dis; 2012 Oct; 3(10):e414. PubMed ID: 23096115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
    Kohlhaas SL; Craxton A; Sun XM; Pinkoski MJ; Cohen GM
    J Biol Chem; 2007 Apr; 282(17):12831-41. PubMed ID: 17327223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis.
    Harper N; Hughes M; MacFarlane M; Cohen GM
    J Biol Chem; 2003 Jul; 278(28):25534-41. PubMed ID: 12721308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains.
    Li S; Zhang L; Yao Q; Li L; Dong N; Rong J; Gao W; Ding X; Sun L; Chen X; Chen S; Shao F
    Nature; 2013 Sep; 501(7466):242-6. PubMed ID: 23955153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.
    Ou D; Wang X; Metzger DL; Robbins M; Huang J; Jobin C; Chantler JK; James RF; Pozzilli P; Tingle AJ
    Hum Immunol; 2005 Jul; 66(7):799-809. PubMed ID: 16112027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling.
    Harper N; Hughes MA; Farrow SN; Cohen GM; MacFarlane M
    J Biol Chem; 2003 Nov; 278(45):44338-47. PubMed ID: 12920112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redundant and receptor-specific activities of TRADD, RIPK1 and FADD in death receptor signaling.
    Füllsack S; Rosenthal A; Wajant H; Siegmund D
    Cell Death Dis; 2019 Feb; 10(2):122. PubMed ID: 30741924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GDP-mannose-4,6-dehydratase (GMDS) deficiency renders colon cancer cells resistant to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor- and CD95-mediated apoptosis by inhibiting complex II formation.
    Moriwaki K; Shinzaki S; Miyoshi E
    J Biol Chem; 2011 Dec; 286(50):43123-33. PubMed ID: 22027835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells.
    Shlyakhtina Y; Pavet V; Gronemeyer H
    Cell Death Dis; 2017 Aug; 8(8):e3025. PubMed ID: 29048428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct signaling pathways in TRAIL- versus tumor necrosis factor-induced apoptosis.
    Jin Z; El-Deiry WS
    Mol Cell Biol; 2006 Nov; 26(21):8136-48. PubMed ID: 16940186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex.
    Kavuri SM; Geserick P; Berg D; Dimitrova DP; Feoktistova M; Siegmund D; Gollnick H; Neumann M; Wajant H; Leverkus M
    J Biol Chem; 2011 May; 286(19):16631-46. PubMed ID: 21454681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin and selenium cooperatively induce fas signaling in the absence of Fas/Fas ligand interaction.
    Li S; Zhou Y; Dong Y; Ip C
    Anticancer Res; 2007; 27(5A):3075-82. PubMed ID: 17970047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD).
    Wajant H; Haas E; Schwenzer R; Muhlenbeck F; Kreuz S; Schubert G; Grell M; Smith C; Scheurich P
    J Biol Chem; 2000 Aug; 275(32):24357-66. PubMed ID: 10823821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L).
    Guseva NV; Rokhlin OW; Taghiyev AF; Cohen MB
    Breast Cancer Res Treat; 2008 Feb; 107(3):349-57. PubMed ID: 17453339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
    Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
    Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8.
    Ikner A; Ashkenazi A
    J Biol Chem; 2011 Jun; 286(24):21546-54. PubMed ID: 21525013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.
    Kischkel FC; Lawrence DA; Chuntharapai A; Schow P; Kim KJ; Ashkenazi A
    Immunity; 2000 Jun; 12(6):611-20. PubMed ID: 10894161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.